Finance

Beta
Lists
CY71:FRA
Anixa Biosciences Inc
€2.12
+4.95%
(+0.100) 1D
Jun 12, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for CY71...
Open
€2.12
High
€2.12
Low
€2.12
Mkt. cap
84.04M
Avg. vol.
906.00
Volume
61.00
52-wk high
€5.00
52-wk low
€2.02
No. of employees
4
Open
€2.12
High
€2.12
Low
€2.12
Mkt. cap
84.04M
Avg. vol.
906.00
Volume
61.00
52-wk high
€5.00
52-wk low
€2.02
No. of employees
4
News stories
From sources across the web
About Anixa Biosciences Inc
CEO-
Employees4
Founded1982
HeadquartersSan Jose, California, United States
SectorBiotechnology
Websiteanixa.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.06M
1.14M
1.10M
1.26M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.38M
1.73M
1.61M
1.39M
Operating expense
2.44M
2.88M
2.72M
2.65M
Total operating expenses
2.44M
2.88M
2.72M
2.65M
Operating income
-2.44M
-2.88M
-2.72M
-2.65M
Other non operating income
-
-
-
-
EBT including unusual items
-2.28M
-2.72M
-2.58M
-2.54M
EBT excluding unusual items
-2.28M
-2.72M
-2.58M
-2.54M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.26M
-2.70M
-2.56M
-2.52M
Net profit margin
-
-
-
-
Earnings per share
-0.07
-0.09
-0.08
-0.07
Interest and investment income
156.00K
154.00K
131.00K
111.00K
Interest expense
-
-
-
-
Net interest expenses
156.00K
154.00K
131.00K
111.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer